Paper Details

  1. Home
  2. Paper Details

Frequency of inhaled metaproterenol in the treatment of acute asthma exacerbation.

Author: HargisC, HofstadterA, NelsonM S, ParkerJ

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Inhaled metaproterenol given frequently during acute asthma exacerbations is safe and effective, leading to improved lung function without increased side effects.
Paper Details　
Original Abstract of the Article :
Acute asthma exacerbations are common complaints in patients who present to the emergency department. A prospective, double-blinded study was designed to evaluate how frequency of dosing of an inhaled beta-agonist, metaproterenol (Alupent inhalation solution) would affect patient response, length of...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0196-0644(05)82134-1

データ提供：米国国立医学図書館（NLM）

Frequency of Inhaled Metaproterenol for Acute Asthma Exacerbations

Asthma exacerbations are a frequent occurrence, often leading patients to seek emergency department care. This study aimed to evaluate the impact of different dosing frequencies of inhaled metaproterenol, a beta-agonist, on patient outcomes. Researchers conducted a prospective, double-blinded trial, comparing the effects of frequent metaproterenol dosing with a control group receiving saline.

Frequent Metaproterenol Dosing: A Promising Strategy

While there was no immediate difference in response between the groups at 30 minutes, the metaproterenol group exhibited improved lung function at 60 and 120 minutes. The study found no significant differences in length of stay or admission rates, indicating that frequent metaproterenol dosing could be a viable strategy for managing acute asthma exacerbations.

Navigating the Sands of Asthma: Finding Relief Through Frequency

This study underscores the importance of individualized treatment approaches for asthma. The findings suggest that frequent metaproterenol dosing can be an effective strategy for achieving rapid relief during acute asthma exacerbations. This research serves as a valuable guide for clinicians seeking to optimize asthma management strategies.

Dr.Camel's Conclusion

This study, like a desert traveler finding respite in an oasis, reveals the effectiveness of frequent metaproterenol dosing for individuals experiencing acute asthma exacerbations. By understanding the benefits of different dosing frequencies, clinicians can better equip patients with the tools they need to navigate the challenges of asthma and achieve optimal respiratory health.
Date :
  1. Date Completed 1990-02-15
  2. Date Revised 2019-07-17
Further Info :

Pubmed ID

2297150

DOI: Digital Object Identifier

10.1016/s0196-0644(05)82134-1

Related Literature

Article Analysis
・Side Effects of metaproterenol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.